CapsoVision (NASDAQ: CV - Get Free Report) and Brainsway (NASDAQ: BWAY - Get Free Report) are both s

NeuroPace (NASDAQ: NPCE - Get Free Report) and CapsoVision (NASDAQ: CV - Get Free Report) are both s

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across

What happened CapsoVision, Inc. (NASDAQ: CV) said AI Highlights, its AI-assisted reading tool for Ca

AI Highlights is designed to support physicians in the review of small bowel capsule endoscopy studi

AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies p

CapsoVision, Inc. (NASDAQ: CV - Get Free Report) major shareholder Eliyahou Et Al Harari acquired 1,

AbbVie Announces European Commission Approval of RINVOQÂ (upadacitinib) for the Treatment of Childre

CapsoVision, Inc.3,163,444 Shares of Common Stock   We are offering 3,163,444 shares of our common s

Zimmer Biomet (NYSE: ZBH - Get Free Report) and CapsoVision (NASDAQ: CV - Get Free Report) are both

BlackRock Inc. purchased a new position in shares of CapsoVision, Inc. (NASDAQ: CV) during the secon

SARATOGA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-st

[url="]Alnylam Pharmaceuticals, Inc[/url]. (Nasdaq: ALNY), the leading RNAi therapeutics company, to

CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript

CapsoVision NASDAQ: CV reported second-quarter revenue growth as sales of its CapsoCam Plus capsule

CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thu

CapsoVision, Inc.$250,000,000Common StockPreferred StockWarrantsRightsUnits    From time to time, we

SARATOGA, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-sta

SARATOGA, Calif. , Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-st

SARATOGA, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-sta

SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-sta

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Ado

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH S

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Mon

CapsoVision (NASDAQ:CV) reported quarterly losses of $(0.15) per share which missed the analyst cons

Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowe

CapsoVision (NASDAQ:CV) reported quarterly earnings of $0.02 per share which beat the analyst consen

CapsoVision, Inc. (the "Company") (NASDAQ: CV), a commercial-stage medical technology compan

U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, C